According to their study, MCF-7 breast cancer cells that express a constitutively active Akt showed resistance to tamoxifen, however, treatment with rapamycin inhibited the growth of resistant cells by 65%, as shown by a cell viability assay. This evidence concerns the gene AKT1 and breast cancer.